文献速递胸部肿瘤放疗放疗物理与技术

大剂量单次放射治疗可能诱导早期非小细胞肺癌肿瘤内缺氧水平升高

High Single Doses of Radiation May Induce Elevated Levels of Hypoxia in Early-Stage Non-Small Cell Lung Cancer Tumors.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2018-06-01

该前瞻性研究纳入6例适合立体定向体部放疗(SBRT)的非小细胞肺癌(NSCLC)患者,用18F-氟米索硝唑PET在18 Gy照射前后系列定量肿瘤缺氧体积(HV)。6例中3例观察到缺氧升高、部分持续存在;基线可检出缺氧的3例HV从基线均值21%升至第2天40%。作者认为大剂量单次照射可能诱导缺氧升高状态。

要点

  • 6例NSCLC患者中3例在18 Gy后出现肿瘤缺氧升高、部分持续存在。
  • 基线可检出缺氧的3例HV基线均值21%,第2天升至40%,第4天为28%。
  • 作者建议在更大队列中用18F-氟米索硝唑PET验证缺氧升高是否预测SBRT治疗失败。

核心结论

  • 作为SBRT组成部分的高单次剂量放射治疗可能诱导NSCLC肿瘤出现缺氧升高、部分病例持续存在的状态。
  • 作者建议在更大规模NSCLC患者队列中使用18F-氟米索硝唑PET缺氧显像,以确定肿瘤缺氧升高是否预测SBRT治疗失败。

研究设计与样本

  • 前瞻性研究,经机构审查委员会批准,纳入6例肿瘤>1 cm且适合SBRT的NSCLC患者。
  • 注射18F-氟米索硝唑后于0至120分钟、150至180分钟、210至240分钟行动态PET显像,并于18 Gy照射前及SBRT后约48小时、约96小时行系列显像。
  • 肿瘤HV以肿瘤与本底血比值(>1.2)和示踪剂流入速率(>0.0015 mL·min·cm-3)定量。

主要发现

  • 6例中3例观察到肿瘤缺氧升高,部分病例持续存在;2例基线未检出肿瘤缺氧;1例基线高缺氧者仅完成1次显像。
  • 基于肿瘤与本底血比值,其余3例在18 Gy后第2天肿瘤HV升高,第4天呈可变反应。
  • 6例中基线可检出缺氧的3例,基线HV为17%至24%(均值21%),第2天HV为33%至45%(均值40%),第4天HV为18%至42%(均值28%)。

关键数值与推荐

  • 肿瘤HV定量采用肿瘤与本底血比值>1.2及示踪剂流入速率>0.0015 mL·min·cm-3。
  • 18F-氟米索硝唑PET显像时间点为注射后0至120分钟、150至180分钟、210至240分钟。
  • 系列显像于18 Gy照射前及SBRT后约48小时和约96小时进行。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 6例中1例基线高缺氧者仅完成1次显像。
  • 作者指出需在更大规模NSCLC患者队列中使用18F-氟米索硝唑PET,以确定缺氧升高是否预测SBRT治疗失败。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Tumor hypoxia correlates with treatment failure in patients undergoing conventional radiation therapy. However, no published studies have investigated tumor hypoxia in patients undergoing stereotactic body radiation therapy (SBRT). We aimed to noninvasively quantify the tumor hypoxic volume (HV) in non-small cell lung cancer (NSCLC) tumors to elucidate the potential role of tumor vascular response and reoxygenation at high single doses. METHODS AND MATERIALS: Six SBRT-eligible patients with NSCLC tumors >1 cm were prospectively enrolled in an institutional review board-approved study. Dynamic positron emission tomography images were acquired at 0 to 120 minutes, 150 to 180 minutes, and 210 to 240 minutes after injection of 18F-fluoromisonidazole. Serial imaging was performed prior to delivery of 18 Gy and at approximately 48 hours and approximately 96 hours after SBRT. Tumor HVs were quantified using the tumor-to-blood ratio (>1.2) and rate of tracer influx (>0.0015 mL·min·cm-3). RESULTS: An elevated and in some cases persistent level of tumor hypoxia was observed in 3 of 6 patients. Two patients exhibited no detectable baseline tumor hypoxia, and 1 patient with high baseline hypoxia only completed 1 imaging session. On the basis of the tumor-to-blood ratio, in the remaining 3 patients, tumor HVs increased on day 2 after 18 Gy and then showed variable responses on day 4. In the 3 of 6 patients with detectable hypoxia at baseline, baseline tumor HVs ranged between 17% and 24% (mean, 21%), and HVs on days 2 and 4 ranged between 33% and 45% (mean, 40%) and between 18% and 42% (mean, 28%), respectively. CONCLUSIONS: High single doses of radiation delivered as part of SBRT may induce an elevated and in some cases persistent state of tumor hypoxia in NSCLC tumors. Hypoxia imaging with 18F-fluoromisonidazole positron emission tomography should be used in a larger cohort of NSCLC patients to determine whether elevated tumor hypoxia is predictive of treatment failure in SBRT.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Kelada OJ, Decker RH, Nath SK, et al. High Single Doses of Radiation May Induce Elevated Levels of Hypoxia in Early-Stage Non-Small Cell Lung Cancer Tumors. Int J Radiat Oncol Biol Phys. 2018. PMID: 30102194. doi:10.1016/j.ijrobp.2018.05.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。